ciprofloxacin has been researched along with methicillin in 94 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 26 (27.66) | 18.7374 |
1990's | 18 (19.15) | 18.2507 |
2000's | 19 (20.21) | 29.6817 |
2010's | 23 (24.47) | 24.3611 |
2020's | 8 (8.51) | 2.80 |
Authors | Studies |
---|---|
Angehrn, P; Buchmann, S; Funk, C; Gmuender, H; Goetschi, E; Hebeisen, P; Kostrewa, D; Link, H; Luebbers, T; Masciadri, R; Nielsen, J; Reindl, P; Ricklin, F; Schmitt-Hoffmann, A; Theil, FP | 1 |
Brouillette, CG; Brouillette, WJ; DeLucas, LJ; Luan, CH; Mou, L; Velu, SE; Yang, ZW | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Ashfaq, MK; Gross, A; Hamann, MT; Ibrahim, MA; Jacob, M; Khan, SI; Mansoor, AA | 1 |
Bunders, C; Huigens, RW; Melander, C; Reed, CS; Reyes, S; Rogers, SA; Steinhauer, AT | 1 |
Mishra, NN; Prabhakar, YS; Saquib, M; Sharma, S; Shaw, AK; Shukla, PK; Srivastava, R; Verma, S | 1 |
Chen, X; Jacob, MR; Khan, IA; Kloepper, JW; Li, XC; Liles, MR; Mead, DA; Nasrin, S; Ravu, RR; Wang, M | 1 |
Dai, HQ; Guo, H; Li, ZS; Song, FH; Wang, JG; Wang, WM; Zhang, LX; Zhang, XM | 1 |
Carballeira, NM; Gutierrez, R; Montano, N; Ortíz-Soto, G; Ríos-Olivares, E; Rivera-Torres, Y; Rodríguez, JW; Rosario, J; Sanabria-Ríos, DJ; Torres-García, Y | 1 |
Giang, NTK; Huong, DT; Quyen, TH; Thanh, ND; Toan, VN | 1 |
Abutaleb, NS; Dayal, N; Mohammad, H; Naclerio, GA; Opoku-Temeng, C; Seleem, MN; Sintim, HO | 1 |
Dang, LH; Dung, TT; Hai, DS; Kim Van, HT; Ky Duyen, NT; Mai, NT; Ngoc Bich, VT; Thanh Van, TT; Thanh, ND; Thu Hien, PT; Toan, DN; Toan, VN | 1 |
Ali, Z; Bae, JY; Chittiboyina, AG; Khan, IA; Viljoen, AM; Wang, YH; Zaki, AA | 1 |
Abouelhassan, Y; Chojnacki, M; Ding, Y; Dunman, PM; Fuse, MA; Huang, G; Huigens, RW; Jin, S; Kallifidas, D; Kundra, S; Lemos, JA; Liu, K; Luesch, H; Rohde, KH; Yang, H; Zhang, P | 1 |
Guo, XC; Huang, XH; Lu, YJ; Ser, HL; She, MT; Sun, N; Wong, WL; Zhang, YH; Zheng, BX; Zhong, DX | 1 |
Cobbs, CG; Smith, KR | 1 |
Blumberg, HM; Kiehlbauch, JA; Rimland, D; Terry, PM; Wachsmuth, IK | 1 |
Lenz, W; Machka, K; Milatovic, D; Voss, A | 1 |
Dryden, MS; Ludlam, HA; Phillips, I | 1 |
Davidson, RJ; Hoban, DJ; Phillips, R; Zhanel, GG | 1 |
Boyle, JF; Cortes, H; Mariuz, P; Merlo, A; Pablos-Mendez, A; Raviglione, MC | 1 |
Budnick, LD; Schaefler, S | 1 |
Powers, JS; Spetalnick, BM | 1 |
Henry, NK; Rouse, MS; Steckelberg, JM; Wilcox, RM; Wilson, WR | 1 |
Dworkin, R; Kunz, S; Modin, G; Rich, R; Sande, M; Zak, O | 1 |
Schaefler, S | 1 |
Albrecht, LM; Barriere, SL; Kaatz, GW; Rybak, MJ; Seo, SM | 1 |
Brumfitt, W; Hamilton-Miller, J; Maple, P | 1 |
Chandrasekar, PH; Sluchak, JA | 1 |
Barbaro, D; Luby, JP; Mackowiak, PA; Piercy, EA | 1 |
Eng, RH; Smith, SM; Tecson-Tumang, F | 1 |
Arakawa, S; Den, S; Gohji, K; Ka, S; Kamidono, S; Maeda, H; Matsui, T; Matsumoto, O; Okada, H; Takagi, S | 1 |
Bawdon, RE; Mackowiak, PA; Piercy, EA | 1 |
Liu, C; Stratton, CW; Weeks, LS | 1 |
Aldridge, KE; Janney, A; Sanders, CV | 1 |
Berman, E; Eng, RH; Smith, SM | 1 |
Bouanchaud, DH; Huet, Y; Rolin, O | 1 |
Smith, SM | 1 |
Rahal, JJ; Simberkoff, MS | 1 |
DiVincenzo, CA; O'Keefe, JP; Tatarowicz, W; Venezio, FR | 1 |
Falkiner, FR; Jones, L; Keane, CT; Mooney, D; Moorhouse, EC; Mulvihill, TE | 1 |
Eng, RH; Smith, SM | 1 |
Fernandez-Guerrero, M; Henry, N; Rouse, M; Wilson, W | 1 |
Abele, B; Blount, R; Hyslop, DL; Westblom, TU | 1 |
Arpi, M; Gahrn-Hansen, B; Søgaard, P | 1 |
Blomquist, I; Johnson, CC; Johnston, L; MacDonald, K; Mulligan, ME; Reinhardt, JF; Ruane, PJ; Statner, B; Wheelock, JP; Wong, P | 1 |
Carpenter, TC; Chambers, HF; Hackbarth, CJ; Sande, MA | 1 |
DiVincenzo, C; Foster, JK; Lentino, JR; Strodtman, R | 1 |
Goering, RV; Sanders, CC; Sanders, WE | 1 |
Barriere, SL; Fekety, R; Kaatz, GW; Schaberg, DR | 1 |
Brass, AS; Weightman, NC | 1 |
Francis, G; Nimmo, GR; Turnidge, JD | 1 |
al-Obaid, IA; Chugh, TD; Jacob, LE; Udo, EE | 1 |
Bonilla, HF; Bradley, SF; Kauffman, CA; Zarins, LT | 1 |
Garcia, R; Raad, I | 1 |
Gottlieb, T; Mitchell, D | 1 |
Firsov, AA; Kononenko, OV; Lubenko, IY; Vasilov, RG; Vostrov, SN; Zinner, SH | 1 |
Chiba, A; Harada, S; Hasegawa, M; Kaneko, A; Kobayashi, I; Koyama, H; Matsuzaki, K; Omika, K; Sasaki, J; Sato, Y | 1 |
Hartnick, CJ; Myer, CM; Shott, S; Willging, JP | 1 |
Bonfiglio, G; Cafiso, V; Campanile, F; Messina, C; Santagati, M; Stefani, S | 1 |
Barrett, JF; Frosco, M; Ho, H; Lawrence, LE; Mazzucco, CE; Ryan, BM; Warr, G | 1 |
Entenza, JM; Moreillon, P | 1 |
Dudzevicius, V; Sakalauskas, R; Vitkauskiene, A | 1 |
Cetin, CB; Cosar, G; Dinç, G; Ermertcan, S; Limoncu, MH | 1 |
Hung, CC; Lauderdale, TL; Lo, HJ; McDonald, LC; Tsai, JJ | 1 |
Alfonso, EC; Marangon, FB; Miller, D; Muallem, MS; Romano, AC | 1 |
Conway, SP; Denton, M; Nadesalingam, K | 1 |
Gailiene, G; Kareiviene, V; Liegiūte, S; Pavilonis, A; Sinkute, G | 1 |
Bosso, JA; Mauldin, PD | 1 |
Berger-Bächi, B; Ender, M; McCallum, N | 1 |
Bartzatt, R; Cirillo, JD; Cirillo, SL | 1 |
Acosta, CJ; Amrine-Madsen, H; Hogea, CS; Lu, EP; Mera, RM; Miller, LA; O'Hara, P; Sahm, DF; Suaya, JA | 1 |
Abbanat, D; Baum, EZ; Crespo-Carbone, SM; Davies, TA; He, W; Lynch, AS; Morrow, BJ; Queenan, AM; Shang, W | 1 |
Dosler, S; Gerceker, AA | 1 |
Bearden, DT; Elman, MR; Gorman, PN; McGregor, JC; Mori, M; Sharp, SE; Smith, DH; Townes, JM | 1 |
De Smet, B; Jacobs, JA; Kham, C; Koole, O; Lim, K; Lynen, L; Peetermans, WE; Phe, T; Veng, HC; Vlieghe, ER | 1 |
Forsblom, E; Järvinen, A; Ruotsalainen, E | 1 |
Camacho-Ortiz, A; Casillas-Vega, N; Garza-González, E; González, GM; Llaca-Díaz, J; Mendoza-Olazarán, S; Morfín-Otero, R; Rodríguez-Noriega, E; Villarreal-Treviño, L | 1 |
Cavallaro, MC; Chehter, N; Del Nero, LG; Marta, GN; Zambon, LS | 1 |
Banerjee, A; Bhattacharya, G; Das, S; Dey, D | 1 |
Chiang, HT; Hsueh, PR; Jan, YN; Kang, MY; Ko, WC; Lai, CC; Lee, CM; Lo, YT; Lu, MC; Tsai, TL; Tseng, SH; Wang, LF | 1 |
Asbell, PA; DeCory, HH | 1 |
Aelenei, P; Aprotosoaie, AC; Brebu, M; Dimitriu, G; Guguianu, E; Horhogea, CE; Miron, A; Rimbu, CM | 1 |
Epps, KL; Epps, QJ; Young, DC; Zobell, JT | 1 |
Mohapatra, PP; Padhi, L; Panda, SK; Sahoo, G | 1 |
Coombs, GW; Daley, DA; Mowlaboccus, S; Shoby, P; Yee, NWT | 1 |
Kim, GB; Kim, SD; Lee, GY; Lee, SI; Park, JH; Yang, SJ | 1 |
Coombs, GW; Daley, DA; Mowlaboccus, S; Shoby, P | 2 |
2 review(s) available for ciprofloxacin and methicillin
Article | Year |
---|---|
Antibiotic resistance: learning from animal feeds and animal experimentation.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; In Vitro Techniques; Methicillin; Models, Animal; Quinolones; Rabbits; Rats; Staphylococcus aureus; Streptococcus | 2001 |
State of the art in cystic fibrosis pharmacology-Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Ciprofloxacin; Clindamycin; Cystic Fibrosis; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin-Resistant Staphylococcus aureus; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2020 |
3 trial(s) available for ciprofloxacin and methicillin
Article | Year |
---|---|
[Incidence, frequency and resistance characteristics of methicillin-oxacillin resistant Staphylococcus aureus strains in Germany].
Topics: Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Fosfomycin; Germany; Humans; Imipenem; Methicillin; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Staphylococcus aureus; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1992 |
Ciprofloxacin therapy for methicillin-resistant Staphylococcus aureus infections or colonizations.
Topics: Ciprofloxacin; Humans; Methicillin; Penicillin Resistance; Staphylococcal Infections | 1989 |
Ciprofloxacin for eradication of methicillin-resistant Staphylococcus aureus colonization.
Topics: Adult; Aged; Aged, 80 and over; Ciprofloxacin; Clinical Trials as Topic; Female; Humans; Male; Methicillin; Middle Aged; Nervous System; Penicillin Resistance; Staphylococcal Infections | 1987 |
89 other study(ies) available for ciprofloxacin and methicillin
Article | Year |
---|---|
New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine.
Topics: Animals; Anti-Bacterial Agents; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; HeLa Cells; Humans; Lactams; Lactones; Mice; Microbial Sensitivity Tests; Models, Molecular; Oxadiazoles; Peptides, Cyclic; Protein Subunits; Staphylococcal Infections; Stereoisomerism; Structure-Activity Relationship; Topoisomerase II Inhibitors; Toxicity Tests | 2004 |
Antibacterial nicotinamide adenine dinucleotide synthetase inhibitors: amide- and ether-linked tethered dimers with alpha-amino acid end groups.
Topics: Amide Synthases; Amides; Amino Acids; Anti-Bacterial Agents; Bacillus subtilis; Detergents; Dimerization; Ethers; Gram-Positive Bacteria; Microbial Sensitivity Tests; NAD; Octoxynol; Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Methicillin-resistant Staphylococcus aureus (MRSA)-active metabolites from Platanus occidentalis (American Sycamore).
Topics: Anti-Bacterial Agents; Glycosides; Kaempferols; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mississippi; Molecular Structure; Stereoisomerism; Trees | 2009 |
The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Benzimidazoles; Drug Resistance, Multiple, Bacterial; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Conformation; Small Molecule Libraries; Stereoisomerism; Structure-Activity Relationship | 2010 |
Synthesis of 2,3,6-trideoxy sugar triazole hybrids as potential new broad spectrum antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Carbohydrates; Catalytic Domain; Cell Line; Chemistry Techniques, Synthetic; Click Chemistry; Drug Design; Fungi; Microbial Sensitivity Tests; Models, Molecular; Penicillin-Binding Proteins; Triazoles | 2014 |
Bacillusin A, an Antibacterial Macrodiolide from Bacillus amyloliquefaciens AP183.
Topics: Anti-Bacterial Agents; Bacillus; Candida albicans; Drug Resistance, Bacterial; Enterococcus faecium; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Polyenes; Staphylococcus aureus; Vancomycin | 2015 |
Synthesis and evaluation of isatin-β-thiosemicarbazones as novel agents against antibiotic-resistant Gram-positive bacterial species.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Isatin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Thiosemicarbazones; Vancomycin-Resistant Enterococci | 2015 |
Chemical conjugation of 2-hexadecynoic acid to C5-curcumin enhances its antibacterial activity against multi-drug resistant bacteria.
Topics: Alkynes; Animals; Anti-Bacterial Agents; Chlorocebus aethiops; Curcumin; DNA Gyrase; DNA, Superhelical; Escherichia coli; Fatty Acids, Unsaturated; Humans; Leukocytes, Mononuclear; Methicillin-Resistant Staphylococcus aureus; Staphylococcus aureus; Topoisomerase II Inhibitors; Vero Cells | 2015 |
Synthesis and evaluation of in vivo antioxidant, in vitro antibacterial, MRSA and antifungal activity of novel substituted isatin N-(2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl)thiosemicarbazones.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antioxidants; Cell Line, Tumor; Chemistry Techniques, Synthetic; Drug Evaluation, Preclinical; Isatin; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Rats; Rats, Wistar; Structure-Activity Relationship; Thiosemicarbazones | 2016 |
N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.
Topics: Animals; Anti-Bacterial Agents; Benzamides; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Methicillin; Mice; Microbial Sensitivity Tests; Molecular Structure; Skin Diseases, Bacterial; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin; Wound Infection | 2018 |
Efficient click chemistry towards novel 1H-1,2,3-triazole-tethered 4H-chromene-d-glucose conjugates: Design, synthesis and evaluation of in vitro antibacterial, MRSA and antifungal activities.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Benzopyrans; Click Chemistry; Drug Design; Fungi; Glucose; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; RAW 264.7 Cells; Triazoles | 2019 |
Anthraquinone-Based Specialized Metabolites from Rhizomes of
Topics: Anthraquinones; Anti-Bacterial Agents; Antifungal Agents; Asphodelaceae; Microbial Sensitivity Tests; Molecular Structure; Rhizome; Spectrum Analysis | 2019 |
A Modular Synthetic Route Involving
Topics: Aniline Compounds; Animals; Anti-Bacterial Agents; Biofilms; Cell Line; Cell Survival; Disease Models, Animal; Drug Design; Female; Halogenation; Humans; Iron; Iron Deficiencies; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Phenazines; Staphylococcal Infections; Structure-Activity Relationship; Wound Healing | 2021 |
Design and synthesis of quinolinium-based derivatives targeting FtsZ for antibacterial evaluation and mechanistic study.
Topics: Amines; Anti-Bacterial Agents; Bacterial Proteins; Cytoskeletal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Staphylococcus aureus; Staphylococcus epidermidis; Structure-Activity Relationship | 2022 |
In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Quinolones; Staphylococcus aureus; Staphylococcus epidermidis | 1992 |
Epidemiologic typing of Staphylococcus aureus by DNA restriction fragment length polymorphisms of rRNA genes: elucidation of the clonal nature of a group of bacteriophage-nontypeable, ciprofloxacin-resistant, methicillin-susceptible S. aureus isolates.
Topics: Bacterial Typing Techniques; Bacteriophages; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Microbial; Epidemiologic Methods; Evaluation Studies as Topic; Genes, Bacterial; Humans; Methicillin; Plasmids; Polymorphism, Restriction Fragment Length; RNA, Bacterial; RNA, Ribosomal; Staphylococcal Infections; Staphylococcus aureus | 1992 |
Ciprofloxacin-resistant methicillin-sensitive Staphylococcus aureus.
Topics: Aged; Ciprofloxacin; Drug Resistance, Microbial; Humans; Methicillin; Staphylococcus aureus | 1991 |
Human serum enhances the postantibiotic effect of fluoroquinolones against Staphylococcus aureus.
Topics: Anti-Infective Agents; Blood Physiological Phenomena; Ciprofloxacin; Culture Media; Humans; Kinetics; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Staphylococcus aureus | 1991 |
Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Bacteriophage Typing; Ciprofloxacin; Drug Resistance, Microbial; Hospitals; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 1990 |
Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in New York health care facilities, 1988. The New York MRSA Study Group.
Topics: Adult; Aged; Aged, 80 and over; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Female; Humans; Male; Methicillin; Middle Aged; New York City; Penicillin Resistance; Risk Factors; Staphylococcus aureus; Staphylococcus Phages | 1990 |
Eradication of methicillin-resistant Staphylococcus aureus colonization with ciprofloxacin.
Topics: Aged; Aged, 80 and over; Ciprofloxacin; Humans; Male; Methicillin; Middle Aged; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus | 1990 |
Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis.
Topics: Animals; Ciprofloxacin; Endocarditis, Bacterial; Humans; Methicillin; Penicillin Resistance; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis | 1990 |
Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis.
Topics: Animals; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Male; Methicillin; Osteomyelitis; Pefloxacin; Penicillin Resistance; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Vancomycin | 1990 |
Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Fleroxacin; Humans; Methicillin; Penicillin Resistance; Staphylococcus aureus | 1989 |
Efficacy of fleroxacin in experimental methicillin-resistant Staphylococcus aureus endocarditis.
Topics: Animals; Ciprofloxacin; Drug Resistance, Microbial; Endocarditis, Bacterial; Fleroxacin; Male; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 1989 |
Ciprofloxacin resistance in methicillin- and gentamicin-resistant Staphylococcus aureus.
Topics: Ciprofloxacin; Coagulase; Drug Resistance, Microbial; Gentamicins; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Staphylococcus aureus | 1989 |
Newer agents against methicillin and/or gentamicin-resistant and -susceptible staphylococci.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Drug Resistance, Microbial; Fluoroquinolones; Gentamicins; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Peptides; Species Specificity; Staphylococcus aureus | 1989 |
Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Humans; Methicillin; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus | 1989 |
[A case report of septicemia caused by methicillin cephem resistant Staphylococcus aureus (MRSA)].
Topics: Ciprofloxacin; Female; Humans; Methicillin; Middle Aged; Penicillin Resistance; Sepsis; Staphylococcal Infections; Staphylococcus aureus | 1989 |
Penetration of ciprofloxacin into saliva and nasal secretions and effect of the drug on the oropharyngeal flora of ill subjects.
Topics: Ciprofloxacin; Humans; Methicillin; Nasal Mucosa; Oropharynx; Penicillin Resistance; Saliva; Staphylococcal Infections | 1989 |
Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.
Topics: Anti-Bacterial Agents; Cefamandole; Cefazolin; Cefuroxime; Ciprofloxacin; Culture Media; Daptomycin; Kinetics; Methicillin; Microbial Sensitivity Tests; Peptides; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1987 |
Ciprofloxacin resistance in epidemic methicillin-resistant Staphylococcus aureus.
Topics: Aged; Ciprofloxacin; Drug Resistance, Microbial; Humans; Male; Methicillin; Staphylococcal Infections; Staphylococcus aureus; Texas | 1988 |
Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations.
Topics: Aminocoumarins; Anti-Bacterial Agents; Bacteriophage Typing; Ciprofloxacin; Coumarins; Glycopeptides; Methicillin; Penicillin Resistance; Quinolines; Staphylococcus aureus; Teicoplanin | 1985 |
The effect of ciprofloxacin on methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Humans; Methicillin; Microbial Sensitivity Tests; Nephelometry and Turbidimetry; Penicillin Resistance; Quinolines; Staphylococcus aureus; Time Factors | 1986 |
Comparative efficacy of pefloxacin and six other antimicrobial agents on Staphylococcus aureus experimental abscesses.
Topics: Abscess; Administration, Oral; Animals; Anti-Bacterial Agents; Cephalothin; Ciprofloxacin; Injections, Subcutaneous; Methicillin; Mice; Norfloxacin; Pefloxacin; Penicillin Resistance; Peptides; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Thigh; Vancomycin; Virginiamycin | 1986 |
In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Methicillin; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Piperazines; Quinolines; Staphylococcus aureus | 1986 |
Bactericidal activity of ciprofloxacin against amikacin- and cefotaxime-resistant gram-negative bacilli and methicillin-resistant staphylococci.
Topics: Amikacin; Cefotaxime; Ciprofloxacin; Cross Infection; Gram-Negative Bacteria; Humans; Kanamycin; Methicillin; Penicillin Resistance; Quinolines; Staphylococcus | 1986 |
Activity of ciprofloxacin against multiply resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, and group JK corynebacteria.
Topics: Actinomycetales; Cefotaxime; Ciprofloxacin; Gentamicins; Humans; Methicillin; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Penicillin Resistance; Pseudomonas aeruginosa; Staphylococcus epidermidis; Ticarcillin; Vancomycin | 1986 |
The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fusidic Acid; Gentamicins; Glycopeptides; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Quinolines; Rifampin; Staphylococcus aureus; Staphylococcus Phages; Teicoplanin; Vancomycin | 1985 |
Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1985 |
Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.
Topics: Animals; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Imipenem; Methicillin; Nafcillin; Penicillin Resistance; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Thienamycins; Vancomycin | 1988 |
Successful oral treatment of methicillin-resistant Staphylococcus aureus osteomyelitis using ciprofloxacin.
Topics: Ciprofloxacin; Humans; Male; Methicillin; Middle Aged; Osteomyelitis; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus | 1988 |
In vitro activity of ciprofloxacin against methicillin-susceptible and methicillin-resistant staphylococci.
Topics: Ciprofloxacin; Dose-Response Relationship, Drug; Methicillin; Penicillin Resistance; Staphylococcus aureus; Staphylococcus epidermidis | 1987 |
Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus.
Topics: Animals; Ciprofloxacin; Endocarditis, Bacterial; Kinetics; Methicillin; Penicillin Resistance; Rabbits; Staphylococcal Infections | 1986 |
Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Gentamicins; Kinetics; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Penicillin Resistance; Staphylococcus aureus; Vancomycin | 1986 |
Overview of preclinical studies with ciprofloxacin.
Topics: Animals; Bacterial Infections; Ciprofloxacin; Drug Evaluation, Preclinical; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Methicillin; Mice; Mutation; Penicillin Resistance | 1987 |
Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis.
Topics: Animals; Ciprofloxacin; Drug Evaluation, Preclinical; Endocarditis, Bacterial; Kinetics; Methicillin; Penicillin Resistance; Rabbits; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1987 |
Ciprofloxacin-resistant methicillin-sensitive Staphylococcus aureus.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Humans; Methicillin; Microbial Sensitivity Tests; Middle Aged; Staphylococcus aureus | 1993 |
Evolution of resistance in Staphylococcus aureus in Australian teaching hospitals. Australian Group on Antimicrobial Resistance (AGAR).
Topics: Australia; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Hospitals, Teaching; Humans; Methicillin; Methicillin Resistance; Penicillins; Retrospective Studies; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 1996 |
Molecular characterization of epidemic ciprofloxacin- and methicillin-resistant Staphylococcus aureus strains colonizing patients in an intensive care unit.
Topics: Anti-Infective Agents; Ciprofloxacin; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Intensive Care Units; Kuwait; Methicillin; Methicillin Resistance; Molecular Epidemiology; Penicillins; Staphylococcal Infections; Staphylococcus aureus | 1996 |
Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to trovafloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus faecium; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Methicillin; Microbial Sensitivity Tests; Naphthyridines; Penicillins; Staphylococcal Infections; Staphylococcus aureus | 1996 |
In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Bacteremia; Catheterization, Central Venous; Cefamandole; Cephalosporins; Ciprofloxacin; Clindamycin; Daptomycin; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Neoplasms; Novobiocin; Oxacillin; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin; Virginiamycin | 1996 |
The independent evolution of resistance to ciprofloxacin, rifampicin, and fusidic acid in methicillin-resistant Staphylococcus aureus in Australian teaching hospitals (1990-1995). Australian Group for Antimicrobial Resistance (AGAR).
Topics: Anti-Bacterial Agents; Australia; Bacteriophage Typing; Ciprofloxacin; Drug Resistance, Multiple; Endemic Diseases; Fusidic Acid; Hospitals, Teaching; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Prevalence; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 1998 |
Prediction of the antimicrobial effects of trovafloxacin and ciprofloxacin on staphylococci using an in-vitro dynamic model.
Topics: Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Dose-Response Relationship, Drug; Fluoroquinolones; Gram-Negative Bacteria; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Naphthyridines; Staphylococcus aureus | 1999 |
[In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
Topics: Ampicillin; Anti-Infective Agents; Bacteria; Bacterial Infections; Cefaclor; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Levofloxacin; Methicillin; Ofloxacin; Penicillin G; Penicillin Resistance; Penicillins | 1999 |
Methicillin-resistant Staphylococcus aureus otorrhea after tympanostomy tube placement: an emerging concern.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Child; Child, Preschool; Chloramphenicol; Chloramphenicol Resistance; Ciprofloxacin; Dexamethasone; Drug Therapy, Combination; Humans; Infant; Methicillin; Methicillin Resistance; Middle Ear Ventilation; Otitis Media with Effusion; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Tobramycin | 2000 |
In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
Topics: Anti-Infective Agents; Ciprofloxacin; Coagulase; Drug Resistance, Microbial; Levofloxacin; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Penicillins; Staphylococcus | 2001 |
Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Topics: Anti-Infective Agents; Blood Bactericidal Activity; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Indoles; Levofloxacin; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Sensitivity and Specificity; Staphylococcus aureus | 2002 |
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchoalveolar Lavage Fluid; Ceftazidime; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcus aureus; Sulbactam; Vancomycin Resistance | 2003 |
Emergence of phenotypic resistance to ciprofloxacin and levofloxacin in methicillin-resistant and methicillin-sensitive Staphylococcus aureus strains.
Topics: Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Levofloxacin; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Phenotype; Serial Passage; Staphylococcus aureus | 2003 |
Colonization of HIV-infected outpatients in Taiwan with methicillin-resistant and methicillin-susceptible Staphylococcus aureus.
Topics: Adult; Aged; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Ciprofloxacin; Cohort Studies; Female; HIV Infections; Humans; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Nasal Cavity; Outpatient Clinics, Hospital; Penicillins; Prevalence; Risk Factors; Staphylococcus aureus; Taiwan; Trimethoprim, Sulfamethoxazole Drug Combination | 2003 |
Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
Topics: Anti-Infective Agents; Ciprofloxacin; Conjunctivitis, Bacterial; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Keratitis; Levofloxacin; Methicillin; Microbial Sensitivity Tests; Ofloxacin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2004 |
Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by patients with cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Chronic Disease; Ciprofloxacin; Cystic Fibrosis; Female; Humans; Length of Stay; Male; Methicillin; Methicillin Resistance; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus | 2005 |
Staphylococcus aureus resistance to antibiotics and spread of phage types.
Topics: Anti-Bacterial Agents; Bacteriophage Typing; Ciprofloxacin; Doxycycline; Drug Resistance, Bacterial; Erythromycin; Fusidic Acid; Gentamicins; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Penicillins; Staphylococcus aureus; Staphylococcus Phages | 2006 |
Using interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Escherichia coli; Fluoroquinolones; Formularies as Topic; Gatifloxacin; Gram-Negative Bacteria; Humans; Levofloxacin; Methicillin; Methicillin Resistance; Ofloxacin; Pseudomonas aeruginosa; Regression Analysis; Retrospective Studies; Staphylococcus aureus | 2006 |
[Otitis externa: which antibiotics are first choice?].
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Humans; Methicillin; Ofloxacin; Ointments; Otitis Externa; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
Variability in SCCmecN1 spreading among injection drug users in Zurich, Switzerland.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Deoxyribonucleases, Type II Site-Specific; DNA Fingerprinting; DNA Transposable Elements; DNA, Bacterial; Fusidic Acid; Humans; Interspersed Repetitive Sequences; Methicillin; Methicillin Resistance; Molecular Epidemiology; Molecular Sequence Data; Penicillin-Binding Proteins; Polymorphism, Restriction Fragment Length; Staphylococcal Infections; Staphylococcus aureus; Substance Abuse, Intravenous; Switzerland; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
Design of ciprofloxacin derivatives that inhibit growth of methicillin resistant Staphylococcus aureus (MRSA) and methicillin susceptible Staphylococcus aureus (MSSA).
Topics: Ciprofloxacin; Drug Design; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship | 2010 |
Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Databases, Factual; Female; Gentamicins; Hospitalization; Humans; Infant; Inpatients; Longitudinal Studies; Male; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multivariate Analysis; Outpatients; Phenotype; Population Surveillance; Prevalence; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2011 |
Antistaphylococcal activities of the new fluoroquinolone JNJ-Q2.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Serial Passage; Staphylococcus aureus | 2011 |
In vitro activities of nisin alone or in combination with vancomycin and ciprofloxacin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains.
Topics: Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Nisin; Staphylococcus aureus; Vancomycin | 2011 |
Comparison of antibiograms developed for inpatients and primary care outpatients.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus; Escherichia coli; Female; Health Maintenance Organizations; Humans; Inpatients; Klebsiella pneumoniae; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Outpatients; Primary Health Care; Pseudomonas aeruginosa; Retrospective Studies; Staphylococcus aureus; Young Adult | 2013 |
Bloodstream infection among adults in Phnom Penh, Cambodia: key pathogens and resistance patterns.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Blood; Cambodia; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Humans; Male; Methicillin; Middle Aged; Sepsis; Young Adult | 2013 |
Methicillin resistant Staphylococcus aureus (MRSA) in India: prevalence & susceptibility pattern.
Topics: Ciprofloxacin; Cross Infection; Erythromycin; Gentamicins; Humans; India; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Soft Tissue Infections; Staphylococcal Infections; Tertiary Care Centers | 2013 |
Improved outcome with early rifampicin combination treatment in methicillin-sensitive Staphylococcus aureus bacteraemia with a deep infection focus - a retrospective cohort study.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Cloxacillin; Drug Therapy, Combination; Female; Finland; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Rifampin; Secondary Prevention; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Time-to-Treatment; Treatment Outcome | 2015 |
Antibiotic Susceptibility of Biofilm Cells and Molecular Characterisation of Staphylococcus hominis Isolates from Blood.
Topics: Amidohydrolases; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Biofilms; Cefoxitin; Chromosomes, Bacterial; Ciprofloxacin; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Humans; Methicillin; Microbial Sensitivity Tests; Operon; Oxacillin; Penicillin-Binding Proteins; Phylogeny; Plankton; Staphylococcal Infections; Staphylococcus hominis; Vancomycin | 2015 |
Near-drowning-associated pneumonia with bacteremia caused by coinfection with methicillin-susceptible Staphylococcus aureus and Edwardsiella tarda in a healthy white man: a case report.
Topics: Adult; Bacteremia; Ceftriaxone; Ciprofloxacin; Clindamycin; Coinfection; Edwardsiella tarda; Enterobacteriaceae Infections; Humans; Male; Methicillin; Near Drowning; Oxacillin; Pneumonia; Staphylococcal Infections; Staphylococcus aureus | 2016 |
Exposure to sub-inhibitory concentrations of gentamicin, ciprofloxacin and cefotaxime induces multidrug resistance and reactive oxygen species generation in meticillin-sensitive Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Methicillin; Microbial Sensitivity Tests; Reactive Oxygen Species; Staphylococcus aureus | 2017 |
Methicillin-resistant Staphylococcus aureus sequence type 45 with high rates of ciprofloxacin and tetracycline resistance in the residents and environments of long-term care facilities in Taiwan.
Topics: Ciprofloxacin; HIV; Humans; Long-Term Care; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; New York; Prisons; Staphylococcal Infections; Staphylococcus aureus; Taiwan; Tetracycline Resistance | 2018 |
Antibiotic resistance among bacterial conjunctival pathogens collected in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Ciprofloxacin; Conjunctiva; Conjunctivitis, Bacterial; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Female; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae; Tobramycin; Trimethoprim; United States | 2018 |
Coriander essential oil and linalool - interactions with antibiotics against Gram-positive and Gram-negative bacteria.
Topics: Acyclic Monoterpenes; Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Coriandrum; Drug Synergism; Escherichia coli; Gas Chromatography-Mass Spectrometry; Gentamicins; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monoterpenes; Oils, Volatile; Oxacillin; Plant Oils; Pseudomonas aeruginosa; Staphylococcus epidermidis; Tetracycline | 2019 |
Antibiotic susceptibility of cultivable aerobic microbiota from the oral cavity of Echis carinatus from Odisha (India).
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Azithromycin; Cefpodoxime; Ceftizoxime; Ciprofloxacin; Gentamicins; Imipenem; Methicillin; Microbial Sensitivity Tests; Microbiota; Mouth; Penicillins; Phylogeny; RNA, Ribosomal, 16S; Viperidae | 2020 |
Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2020.
Topics: Agar; Anti-Bacterial Agents; Anti-Infective Agents; Australia; Bacteremia; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Erythromycin; Gentamicins; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Tetracyclines | 2022 |
Clonal distribution and antimicrobial resistance of methicillin-susceptible and -resistant Staphylococcus aureus strains isolated from broiler farms, slaughterhouses, and retail chicken meat.
Topics: Abattoirs; Animals; Anti-Bacterial Agents; Chickens; Ciprofloxacin; Drug Resistance, Bacterial; Farms; Fluoroquinolones; Genotype; Meat; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Surveillance Outcome Program (ASSOP).
Topics: Agar; Anti-Bacterial Agents; Anti-Infective Agents; Australia; Bacteremia; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Erythromycin; Gentamicins; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Tetracycline | 2022 |
Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Surveillance Outcome Program (ASSOP) Bloodstream Infection Annual Report 2022.
Topics: Agar; Anti-Bacterial Agents; Anti-Infective Agents; Australia; Bacteremia; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Erythromycin; Gentamicins; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Staphylococcus aureus; Tetracycline | 2023 |